Phase One trials are now complete and selective stem cell placement (SSCP) has been confirmed as a potential breakthrough therapy for the treatment of Multiple Sclerosis. SSCP is a delivery technology with a demonstrated scienti?c and clinical proof of concept. This is the first time that a potential therapy has strongly demonstrated a return of function for patients. Linda Friesen is one of many study subjects who have had the SSCP therapy and as a result, have recovered function as their lives returned to ‘normalcy’, absent of symptoms and without the need for medications.
Dewayne has a strong family history of Alzheimer’s disease and he’s always known that it could be in his future. So, he decided to volunteer for a study at UT Southwestern’s Alzheimer’s Disease Center where he could contribute to research efforts and be monitored for signs of cognitive impairment. His decision to volunteer changed his life and set him on a new course.
On the surface, Holden looks like the typical ten-year-old boy — soccer jersey, blonde hair and blue eyes, even freckles. But spend some time with him and you will realize that he is dealing with a chronic illness, Crohn’s disease, that makes his life anything but ordinary.
National Cancer Institute Center for Cancer Research scientist and physician, Lauren V. Wood, M.D., discusses immunotherapy and cancer. Immunotherapy is a type of biological therapy that uses substances to stimulate or suppress the immune system to help the body fight cancer, infection, and other diseases.
NIH-supported ResearchMatch.org helps volunteers and researchers connect for clinical trials. Researchers and clinical trial participants explain what it’s like to volunteer for a trial and how it promotes medical advances.